Unilife Corp

Unilife — Shareholder Meeting (November 2014)

32 slides from Unilife's shareholder meeting presentation, Nov 14, 2014

  1. Slide 1: Annual General Meeting Fiscal Year 2014

    Confidential-Unilife Corporation November 13, 2014 Annual General Meeting Fiscal Year 2014 Exhibit 99.2

  2. Slide 2: Cautionary Note Regarding Forward-Looking Statements

    Confidential-Unilife Corporation November 13, 2014 This presentation contains forward looking statements under the safe harbor provisions of the US securities laws. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to our manage

  3. Slide 3: Welcome. Mr. Alan Shortall, Chairman and CEO

    Confidential-Unilife Corporation Welcome. Mr. Alan Shortall. Chairman and CEO

  4. Slide 4: Introducing our Board of Directors In Attendance

    Confidential-Unilife Corporation Introducing our Board of Directors In Attendance Jim Bosnjak OAM Mary Kate Wold, J.D. John Lund, CPA William Galle Deputy Chairman Director since 2002 Chair of the Compensation Committee Non-Executive Director since 2010 Chair of Strategic Partnerships Committee Non-

  5. Slide 5: Introducing our Board of Directors Apologies

    Confidential-Unilife Corporation Introducing our Board of Directors Apologies Jeff Carter MApp. BFin Non-Executive Director since 2006 Based in Australia •

  6. Slide 6: Agenda

    Agenda 1. Confirmation of Quorum 2. Resolutions 3. Presentation from the CEO 4. Questions 5. Confirmation of Results 6. Other Business

  7. Slide 7: Resolutions

    Resolutions 1.00 Election of Directors 1.01 Elect Slavko James Joseph Bosnjak 1.02 Elect Jeff Carter 1.03 Elect William Galle 1.04 Elect John Lund 1.05 Elect Mary Katherine Wold 1.06 Elect Alan Shortall 2.00 Ratification of Auditor 3.00 Advisory Vote on Executive Compensation 4.00 Ratify Placement o

  8. Slide 8: Confirmation of Quorum

    Confirmation of Quorum • Unilife ’ s quorum requirement is one-third of outstanding shares being represented either in person or by proxy • At least 55.70% of the total outstanding shares entitled to vote have been received and are represented by person or proxy

  9. Slide 9: Business Update

    Confidential-Unilife Corporation Business Update

  10. Slide 10: A Preferred Partner Serving Customer Needs

    • Customer-centric • Market-leading product portfolio • High-caliber team • Deep technical capabilities • Strong partners • Execution with speed A Preferred Partner Serving Customer Needs

  11. Slide 11: Capitalizing on Converging Market Needs

    Patients Pharmaceutical companies Healthcare providers Value Capitalizing on Converging Market Needs

  12. Slide 12: Our Business Model

    Our Business Model • Business to business (attractive operating margins) • Multiple shots on goal per customer • Long-term supply agreements • Predictable, recurring revenue • New agreements provide incremental revenue and growth

  13. Slide 13: Our Commercial Supply Agreements

    Our Commercial Supply Agreements.

  14. Slide 14: Our Commercial Pipeline

    Our Commercial Pipeline 15 active programs A leading indicator of the future supply agreements

  15. Slide 15: Scaling up to Meet Accelerating Demand

    A strategic global alliance Scaling up to Meet Accelerating Demand

  16. Slide 16: Building Long-Term Shareholder Value

    Building Long-Term Shareholder Value

  17. Slide 17: Building Value. Maximizing Revenue.

    Building Value. Maximizing Revenue. • Continuing to invest in business opportunities that generate substantial incremental revenue, and maximize value • Going cash flow positive is a question of when we choose to do so • Continuing to ramp up over the next two years and go commercial with a growing

  18. Slide 18: Annual General Meeting of Stockholders

    Confidential-Unilife Corporation Annual General Meeting of Stockholders November 14, 2014 Consider and Vote for Matters set forth in Proxy Statement

  19. Slide 19: Election of Directors

    Election of Directors Item 1.

  20. Slide 20: Election of Directors Results

    For Withheld Item 1.1 Jim Bosnjak 41,718,199 96.4% 1,559,173 3.6% Item 1.2 Jeff Carter 40,696,315 94.04% 2,581,057 5.96% Item 1.3 William Galle 41,879,595 96.77% 1,397,777 3.23% Item 1.4 John Lund 42,342,898 97.84% 934,474 2.16% Item 1.5 Mary Kate Wold 42,603,519 98.44% 673,853 1.56% Item 1.6 Alan S

  21. Slide 21: Item 2. Ratification of Auditor

    Item 2. Ratification of the appointment of KPMG LLP as the Corporation’s independent registered public accounting firm for Fiscal Year 2015

  22. Slide 22: Item 2 Voting Results

    For Against Abstain Item 2. Ratification of the appointment of KPMG LLP as the Corporation’s independent registered public accounting firm for Fiscal Year 2015 Item 2. 60,485,400 (99.48%) 210,006 (0.35%) 100,479 (0.17%)

  23. Slide 23: Item 3. Advisory Vote on Executive Compensation

    To consider and act on an advisory vote regarding the approval and compensation paid to certain executive officers Item 3.

  24. Slide 24: Item 3 Voting Results

    For Against Abstain To consider and act on an advisory vote regarding the approval and compensation paid to certain executive officers Item 2. 34,117,944 (78.84%) 8,356,877 (19.31%) 802,551 (1.85%) Item 3.

  25. Slide 25: Item 4. Ratify Cantor Share Issuance

    Item 4. To ratify the issuance and sale of 7,308,800 shares of common stock under the controlled equity offering sales agreement entered into with Cantor Fitzgerald.

  26. Slide 26: Item 4 Voting Results

    For Against Abstain Item 4. To ratify the issuance and sale of 7,308,800 shares of common stock under the controlled equity offering sales agreement entered into with Cantor Fitzgerald. Item 4. 40,868,342 (94.44%) 1,909,643 (4.41%) 499,387 (1.15%)

  27. Slide 27: Item 5. 2009 Stock Incentive Plan

    Item 5. To approve the issue and transfer of securities under the 2009 Stock Incentive Plan and approval of the 2009 Stock Incentive Plan as amended.

  28. Slide 28: Item 5 Voting Results

    For Against Abstain Item 5. To approve the issue and transfer of securities under the 2009 Stock Incentive Plan and approval of the 2009 Stock Incentive Plan as amended. Item 5. 34,584,320 (79.92%) 8,289,250 (19.15%) 403,802 (0.93%)

  29. Slide 29: Item 6. Restricted Stock to Alan Shortall

    Item 6. To ratify the issue of up to 4,000,000 shares of restricted stock to Alan Shortall.

  30. Slide 30: Item 6 Voting Results

    For Against Abstain Item 6. To ratify the issue of up to 4,000,000 shares of restricted stock to Alan Shortall. Item 6. 32,693,354 (75.54%) 10,027,717 (23.17%) 556,301 (1.29%)

  31. Slide 31: Final Comments

    Confidential-Unilife Corporation Final Comments

  32. Slide 32: Close of Meeting

    Confidential-Unilife Corporation Close of Meeting

Unilife — Shareholder Meeting (November 2014) on 6ix